Qingdao Baheal Medical Inc
SZSE:301015
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Intangible Assets
Qingdao Baheal Medical Inc
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Intangible Assets
ÂĄ104.6m
|
CAGR 3-Years
50%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Intangible Assets
ÂĄ10.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Intangible Assets
ÂĄ6.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Intangible Assets
ÂĄ2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Intangible Assets
ÂĄ386.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
19%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Intangible Assets
ÂĄ3.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
See Also
What is Qingdao Baheal Medical Inc's Intangible Assets?
Intangible Assets
104.6m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Intangible Assets amounts to 104.6m CNY.
What is Qingdao Baheal Medical Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
23%
Over the last year, the Intangible Assets growth was 84%. The average annual Intangible Assets growth rates for Qingdao Baheal Medical Inc have been 50% over the past three years , 23% over the past five years .